Status:
RECRUITING
Effects of Chestnuts on Postprandial Glycaemic Response
Lead Sponsor:
Monash University
Conditions:
Postprandial Glycemia
Insulin Resistance
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Nut consumption is known to improve health outcomes, such as reducing the risk of chronic diseases like diabetes, cognitive impairment, and cardiovascular diseases. While most research has focused on ...
Eligibility Criteria
Inclusion
- Adults 18-65 years old
- Available to attend two testing sessions at the research facility
Exclusion
- Allergy to nuts and/or gluten,
- BMI\<18.5 or ≥30 kg/m2,
- Fasting glucose \>5.6 mmol/L, presence of diabetes and/or taking anti-diabetic medication
- Serious health conditions that may affect participation e.g. liver or thyroid dysfunction, recent major surgery,
- Smoker,
- Cardiovascular disease
- Pregnant or breastfeeding women
- Presence of implanted cardiac defibrillator
Key Trial Info
Start Date :
June 6 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06960967
Start Date
June 6 2025
End Date
April 1 2026
Last Update
September 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Monash University
Melbourne, Victoria, Australia